Skip to main content
Mary (Lee) Kwok, MD, Oncology, Seattle, WA

MaryLee(Lee)KwokMD

Oncology Seattle, WA

Hematologic Oncology

Clinical Associate Professor, Hematology, University of Washington

Dr. Kwok is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kwok's full profile

Already have an account?

  • Office

    1354 Aloha St
    Seattle, WA 98109
    Phone+1 206-606-2963

Education & Training

  • National Capital Consortium
    National Capital ConsortiumFellowship, Hematology and Medical Oncology, 2009 - 2012
  • National Capital Consortium
    National Capital ConsortiumResidency, Internal Medicine, 2006 - 2009
  • UniforMed Services University of the Health Sciences F. Edward Hebert School of Medicine
    UniforMed Services University of the Health Sciences F. Edward Hebert School of MedicineClass of 2006

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2020 - 2026
  • ID State Medical License
    ID State Medical License 2022 - 2025
  • VA State Medical License
    VA State Medical License 2007 - 2020
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Lectures

  • A Phase 2 Study of Carfilzomib, Lenalidomide, and Dexamethasone with Lenalidomide Maintenance (KRd-r) in Newly Diagnosed Multiple Myeloma (NDMM): Sustained Long Term D... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • FDA Oncologic Drugs Advisory Committee Votes in Favor of Cilta-Cel as Early Treatment for Multiple Myeloma
    FDA Oncologic Drugs Advisory Committee Votes in Favor of Cilta-Cel as Early Treatment for Multiple MyelomaMarch 30th, 2024